BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20053995)

  • 21. Prolactin (PRL) and prolactin receptor (PRLR) genes and their role in poultry production traits.
    Wilkanowska A; Mazurowski A; Mroczkowski S; Kokoszyński D
    Folia Biol (Krakow); 2014; 62(1):1-8. PubMed ID: 24745142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERα and STAT5.
    Kavarthapu R; Tsai Morris CH; Dufau ML
    Oncotarget; 2014 Oct; 5(19):9079-91. PubMed ID: 25193864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of prolactin (PRL) and PRL receptor (PRLR) in Chinese soft-shelled turtle: Molecular identification, ligand-receptor interaction and tissue distribution.
    Yang M; Yang M; Lin Y; Meng F; Du X; Zeng X; Bu G
    Gen Comp Endocrinol; 2022 Jan; 316():113941. PubMed ID: 34715089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolactin and its receptor are expressed in murine hair follicle epithelium, show hair cycle-dependent expression, and induce catagen.
    Foitzik K; Krause K; Nixon AJ; Ford CA; Ohnemus U; Pearson AJ; Paus R
    Am J Pathol; 2003 May; 162(5):1611-21. PubMed ID: 12707045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of subdomain D1 of the short form S1b of the human prolactin receptor on its inhibitory action on the function of the long form of the receptor induced by prolactin.
    Kang JH; Hassan SA; Zhao P; Tsai-Morris CH; Dufau ML
    Biochim Biophys Acta; 2014 Jul; 1840(7):2272-80. PubMed ID: 24735798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism for ordered receptor binding by human prolactin.
    Sivaprasad U; Canfield JM; Brooks CL
    Biochemistry; 2004 Nov; 43(43):13755-65. PubMed ID: 15504038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Essential role of endogenous prolactin and CDK7 in estrogen-induced upregulation of the prolactin receptor in breast cancer cells.
    Kavarthapu R; Dufau ML
    Oncotarget; 2017 Apr; 8(16):27353-27363. PubMed ID: 28423697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pregnancy Hyperglycemia in Prolactin Receptor Mutant, but Not Prolactin Mutant, Mice and Feeding-Responsive Regulation of Placental Lactogen Genes Implies Placental Control of Maternal Glucose Homeostasis.
    Rawn SM; Huang C; Hughes M; Shaykhutdinov R; Vogel HJ; Cross JC
    Biol Reprod; 2015 Sep; 93(3):75. PubMed ID: 26269505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional heterodimerization of prolactin and growth hormone receptors by ovine placental lactogen.
    Herman A; Bignon C; Daniel N; Grosclaude J; Gertler A; Djiane J
    J Biol Chem; 2000 Mar; 275(9):6295-301. PubMed ID: 10692427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyrotropin-releasing hormone and oestrogen differentially regulate prolactin and prolactin receptor expression in female human skin and hair follicles in vitro.
    Langan EA; Ramot Y; Hanning A; Poeggeler B; Bíró T; Gaspar E; Funk W; Griffiths CE; Paus R
    Br J Dermatol; 2010 May; 162(5):1127-31. PubMed ID: 20302576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.
    Lee SA; Haiman CA; Burtt NP; Pooler LC; Cheng I; Kolonel LN; Pike MC; Altshuler D; Hirschhorn JN; Henderson BE; Stram DO
    BMC Med Genet; 2007 Dec; 8():72. PubMed ID: 18053149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ligand-independent dimerization of the human prolactin receptor isoforms: functional implications.
    Gadd SL; Clevenger CV
    Mol Endocrinol; 2006 Nov; 20(11):2734-46. PubMed ID: 16840534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice.
    Bole-Feysot C; Goffin V; Edery M; Binart N; Kelly PA
    Endocr Rev; 1998 Jun; 19(3):225-68. PubMed ID: 9626554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolactin and its receptor as therapeutic targets in glioblastoma multiforme.
    Asad AS; Nicola Candia AJ; Gonzalez N; Zuccato CF; Abt A; Orrillo SJ; Lastra Y; De Simone E; Boutillon F; Goffin V; Seilicovich A; Pisera DA; Ferraris MJ; Candolfi M
    Sci Rep; 2019 Dec; 9(1):19578. PubMed ID: 31862900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of the improved antagonistic prolactin variants by library screening.
    Liu Y; Gong W; Breinholt J; Nørskov-Lauritsen L; Zhang J; Ma Q; Chen J; Panina S; Guo W; Li T; Zhang J; Kong M; Liu Z; Mao J; Christensen L; Hu S; Wang L
    Protein Eng Des Sel; 2011 Nov; 24(11):855-60. PubMed ID: 21954059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of ligand binding determinants of the prolactin receptor.
    Rozakis-Adcock M; Kelly PA
    J Biol Chem; 1992 Apr; 267(11):7428-33. PubMed ID: 1559983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.
    Dandawate P; Kaushik G; Ghosh C; Standing D; Ali Sayed AA; Choudhury S; Subramaniam D; Manzardo A; Banerjee T; Santra S; Ramamoorthy P; Butler M; Padhye SB; Baranda J; Kasi A; Sun W; Tawfik O; Coppola D; Malafa M; Umar S; Soares MJ; Saha S; Weir SJ; Dhar A; Jensen RA; Thomas SM; Anant S
    Gastroenterology; 2020 Apr; 158(5):1433-1449.e27. PubMed ID: 31786131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The WSXWS motif in cytokine receptors is a molecular switch involved in receptor activation: insight from structures of the prolactin receptor.
    Dagil R; Knudsen MJ; Olsen JG; O'Shea C; Franzmann M; Goffin V; Teilum K; Breinholt J; Kragelund BB
    Structure; 2012 Feb; 20(2):270-82. PubMed ID: 22325776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of growth factor receptor function by isoform heterodimerization.
    Chang WP; Clevenger CV
    Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5947-52. PubMed ID: 8650199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of pure prolactin receptor antagonists.
    Bernichtein S; Kayser C; Dillner K; Moulin S; Kopchick JJ; Martial JA; Norstedt G; Isaksson O; Kelly PA; Goffin V
    J Biol Chem; 2003 Sep; 278(38):35988-99. PubMed ID: 12824168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.